GAIN THERAPEUTICS, INC Income Tax Expense
GAIN THERAPEUTICS, INC (GANX) reported Income Tax Expense of $104.07 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-11
- GAIN THERAPEUTICS, INC income tax expense (benefit) for the quarter ending 2026-06-30 was $104.07K, a 26.30% decline year-over-year.
- GAIN THERAPEUTICS, INC income tax expense (benefit) for the quarter ending 2026-03-31 was $183.07K, a 82.14% increase year-over-year.
- GAIN THERAPEUTICS, INC income tax expense (benefit) for the quarter ending 2025-12-31 was $70.12K, a 86.11% decline year-over-year.
- GAIN THERAPEUTICS, INC income tax expense (benefit) for the quarter ending 2025-09-30 was $549.29K, a 4896.25% increase year-over-year.
- GAIN THERAPEUTICS, INC income tax expense (benefit) for fiscal 2025 was $861.12K, a 60.41% increase from fiscal 2024.
- GAIN THERAPEUTICS, INC income tax expense (benefit) for fiscal 2024 was $536.82K, a 577.16% increase from fiscal 2023.
- GAIN THERAPEUTICS, INC income tax expense (benefit) for fiscal 2023 was $79.28K, a 14.74% decline from fiscal 2022.
- GAIN THERAPEUTICS, INC income tax expense (benefit) for fiscal 2022 was $92.98K, a 2219.76% increase from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $104.07K 10-Q · filed 2026-08-11 | $287.14K 10-Q · filed 2026-08-11 | $357.25K derived: sum of 3 quarters · filed 2026-08-11 | $906.54K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $183.07K 10-Q · filed 2026-05-11 | $253.18K derived: sum of 2 quarters · filed 2026-05-11 | $802.47K derived: sum of 3 quarters · filed 2026-05-11 | $943.67K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $70.12K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $619.40K derived: sum of 2 quarters · filed 2026-03-26 | $760.61K derived: sum of 3 quarters · filed 2026-08-11 | $861.12K 10-K · filed 2026-03-26 |
| 2025-09-30 | $549.29K 10-Q · filed 2025-11-12 | $690.49K derived: sum of 2 quarters · filed 2026-08-11 | $791.00K 10-Q · filed 2025-11-12 | $1.30M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $141.21K 10-Q · filed 2026-08-11 | $241.71K 10-Q · filed 2026-08-11 | $746.45K derived: sum of 3 quarters · filed 2026-08-11 | $757.45K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $100.51K 10-Q · filed 2026-05-11 | $605.25K derived: sum of 2 quarters · filed 2026-05-11 | $616.24K derived: sum of 3 quarters · filed 2026-05-11 | $617.45K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $504.74K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $515.73K derived: sum of 2 quarters · filed 2026-03-26 | $516.94K derived: sum of 3 quarters · filed 2026-03-26 | $536.82K 10-K · filed 2026-03-26 |
| 2024-09-30 | $10.99K 10-Q · filed 2025-11-12 | $12.20K derived: sum of 2 quarters · filed 2025-11-12 | $32.08K 10-Q · filed 2025-11-12 | $46.58K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.21K 10-Q · filed 2025-08-12 | $21.08K 10-Q · filed 2025-08-12 | $35.59K derived: sum of 3 quarters · filed 2025-08-12 | $57.04K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $19.87K 10-Q · filed 2025-05-14 | $34.38K derived: sum of 2 quarters · filed 2025-05-14 | $55.83K derived: sum of 3 quarters · filed 2025-05-14 | $82.42K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $14.50K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $35.96K derived: sum of 2 quarters · filed 2025-03-27 | $62.55K derived: sum of 3 quarters · filed 2025-03-27 | $79.28K 10-K · filed 2025-03-27 |
| 2023-09-30 | $21.46K 10-Q · filed 2024-11-14 | $48.05K derived: sum of 2 quarters · filed 2024-11-14 | $64.77K 10-Q · filed 2024-11-14 | $142.88K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $26.59K 10-Q · filed 2024-08-08 | $43.32K 10-Q · filed 2024-08-08 | $121.42K derived: sum of 3 quarters · filed 2024-08-08 | $125.47K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $16.73K 10-Q · filed 2024-05-14 | $94.83K derived: sum of 2 quarters · filed 2024-05-14 | $98.88K derived: sum of 3 quarters · filed 2024-05-14 | $108.03K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $78.11K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $82.15K derived: sum of 2 quarters · filed 2024-03-26 | $91.30K derived: sum of 3 quarters · filed 2024-03-26 | $92.98K 10-K · filed 2024-03-26 |
| 2022-09-30 | $4.05K 10-Q · filed 2023-11-14 | $13.19K derived: sum of 2 quarters · filed 2023-11-14 | $14.87K 10-Q · filed 2023-11-14 | $6.63K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $9.15K 10-Q · filed 2023-08-10 | $10.82K 10-Q · filed 2023-08-10 | $2.58K derived: sum of 3 quarters · filed 2023-08-10 | $7.69K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.68K 10-Q · filed 2023-05-12 | -$6.57K derived: sum of 2 quarters · filed 2023-05-12 | -$1.45K derived: sum of 3 quarters · filed 2023-05-12 | $2.21K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$8.24K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$3.13K derived: sum of 2 quarters · filed 2023-03-23 | $530.00 derived: sum of 3 quarters · filed 2023-03-23 | $4.01K 10-K · filed 2023-03-23 |
| 2021-09-30 | $5.11K 10-Q · filed 2022-11-10 | $8.77K derived: sum of 2 quarters · filed 2022-11-10 | $12.25K 10-Q · filed 2022-11-10 | $10.88K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $3.66K 10-Q · filed 2022-08-08 | $7.14K 10-Q · filed 2022-08-08 | $5.77K derived: sum of 3 quarters · filed 2022-08-08 | $6.66K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $3.48K 10-Q · filed 2022-05-16 | $2.11K derived: sum of 2 quarters · filed 2022-05-16 | $3.00K derived: sum of 3 quarters · filed 2022-05-16 | $7.52K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$1.37K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | -$483.00 derived: sum of 2 quarters · filed 2022-03-25 | $4.04K derived: sum of 3 quarters · filed 2022-03-25 | $5.39K 10-K · filed 2022-03-25 |
| 2020-09-30 | $885.00 10-Q · filed 2021-11-12 | $5.41K derived: sum of 2 quarters · filed 2021-11-12 | $6.75K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $4.52K 10-Q · filed 2021-08-12 | $5.87K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $1.35K 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |